Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | ||||
| Net Income | N/A | -81,604 | N/A | -56,351 |
| Depreciation Amortization | N/A | -222 | N/A | -825 |
| Accounts payable and accrued liabilities | N/A | 491 | N/A | -1,188 |
| Other Working Capital | N/A | -11,114 | N/A | -2,542 |
| Other Operating Activity | 0 | 1,141 | 0 | 3,579 |
| Operating Cash Flow | $N/A | $-91,308 | $N/A | $-57,327 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | N/A | -80,557 | N/A | -112,518 |
| PPE Investments | N/A | -97 | N/A | -664 |
| Investing Cash Flow | $N/A | $-80,654 | $N/A | $-113,182 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 112 | N/A | 272 |
| Other Financing Activity | 0 | 197,743 | 0 | 117,783 |
| Financing Cash Flow | $N/A | $197,855 | $N/A | $118,055 |
| Beginning Cash Position | N/A | 38,460 | N/A | 80,003 |
| End Cash Position | N/A | 64,353 | N/A | 27,549 |
| Net Cash Flow | $N/A | $25,893 | $N/A | $-52,454 |
| Free Cash Flow | ||||
| Operating Cash Flow | N/A | -91,308 | N/A | -57,327 |
| Capital Expenditure | N/A | -97 | N/A | -664 |
| Free Cash Flow | 0 | -91,405 | 0 | -57,991 |